Abordaje integral del cáncer gástrico avanzado - page 29

TRATAMIENTO ANTINEOPLÁSICO

1ª Línea

- Ramucirumab.

- Doble bloqueo Her-2

- Inmunoterapia

- Subtipos moleculares

- Subtipos histológicos

2ª Línea y …

- Angiogénesis.

- Resistencia a Her-2

- Inmunoterapia

Lordick F, et al. Nat rev Clin Oncol 2016

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,19,20,21,22,23,24,25,26,27,28 30,31,32,33,34,35,36,37,38,39,...65